Crystal Parney|April 5, 2024PRENOSIS ANNOUNCES FDA DE NOVO MARKETING AUTHORIZATION OF THE SEPSIS IMMUNOSCORE™, ITS REVOLUTIONARY ARTIFICIAL INTELLIGENCE DIAGNOSTIC AND PREDICTIVE TOOL FOR EARLY SEPSIS DETECTION